Who
Kathleen Goetz
Director
Company insider
Files Form 4 as: Director, Aurinia Pharmaceuticals; Director, abrdn Healthcare Investors Shares of Beneficial Interest; Director, abrdn Life Sciences Investors Shares of Beneficial Interest; Director, abrdn Healthcare Opportunities Fund Shares of Beneficial Interest; Director, abrdn World Healthcare Fund Shares of Beneficial Interest.
In numbers
- Trades disclosed
- 15
- Buys
- 12
- Sells
- 0
- Bought
- $76K
- Sold
- $0
- Companies
- 5
- Companies where not an officer
- 5
- First trade
- 26 Jan 2022
- Last trade
- 4 Jun 2026
- Last filed
- 8 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Jun 2026filed 8 Jun 2026 | AUPH Aurinia Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —23,931 at $0.00 | filing |
| 4 Jun 2026filed 8 Jun 2026 | AUPH Aurinia Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —23,931 at $0.00 | filing |
| 16 May 2025filed 16 May 2025 | AUPH Aurinia Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —63,724 at $0.00 | filing |
| 9 Apr 2024filed 12 Apr 2024 | HQH abrdn Healthcare Investors Shares of Beneficial InterestFunds, Shells & SPACs | SEC FORM 4 Bought | $8,621525 at $16.42 | filing |
| 9 Apr 2024filed 12 Apr 2024 | HQL abrdn Life Sciences Investors Shares of Beneficial InterestFunds, Shells & SPACs | SEC FORM 4 Bought | $5,328400 at $13.32 | filing |
| 9 Apr 2024filed 12 Apr 2024 | THQ abrdn Healthcare Opportunities Fund Shares of Beneficial InterestFunds, Shells & SPACs | SEC FORM 4 Bought | $12K600 at $19.54 | filing |
| 9 Apr 2024filed 12 Apr 2024 | THW abrdn World Healthcare Fund Shares of Beneficial InterestFunds, Shells & SPACs | SEC FORM 4 Bought | $2,506200 at $12.53 | filing |
| 23 Mar 2022filed 24 Mar 2022 | HQL abrdn Life Sciences Investors Shares of Beneficial InterestFunds, Shells & SPACs | SEC FORM 4 Bought | $1,50292.31 at $16.27 | filing |
| 23 Mar 2022filed 24 Mar 2022 | HQH abrdn Healthcare Investors Shares of Beneficial InterestFunds, Shells & SPACs | SEC FORM 4 Bought | $1,50173.53 at $20.42 | filing |
| 23 Mar 2022filed 24 Mar 2022 | THQ abrdn Healthcare Opportunities Fund Shares of Beneficial InterestFunds, Shells & SPACs | SEC FORM 4 Bought | $1,50169.19 at $21.69 | filing |
| 23 Mar 2022filed 24 Mar 2022 | THW abrdn World Healthcare Fund Shares of Beneficial InterestFunds, Shells & SPACs | SEC FORM 4 Bought | $1,501103.38 at $14.52 | filing |
| 26 Jan 2022filed 27 Jan 2022 | HQL abrdn Life Sciences Investors Shares of Beneficial InterestFunds, Shells & SPACs | SEC FORM 4 Bought | $10K593 at $17.54 | filing |
| 26 Jan 2022filed 27 Jan 2022 | HQH abrdn Healthcare Investors Shares of Beneficial InterestFunds, Shells & SPACs | SEC FORM 4 Bought | $10K481 at $21.52 | filing |
| 26 Jan 2022filed 27 Jan 2022 | THQ abrdn Healthcare Opportunities Fund Shares of Beneficial InterestFunds, Shells & SPACs | SEC FORM 4 Bought | $10K479 at $21.73 | filing |
| 26 Jan 2022filed 27 Jan 2022 | THW abrdn World Healthcare Fund Shares of Beneficial InterestFunds, Shells & SPACs | SEC FORM 4 Bought | $10K714 at $14.60 | filing |
News
No headline names them, or the companies they trade most, lately.